Authors
Latest:
Overcoming the wet AMD treatment gapA key distinction between patients seen in the clinic vs those enrolled in clinical trials has to do with characteristics dictated by the trial’s inclusion/exclusion criteria.
Latest:
Successful ocular surgery in patients with chronic uveitisWhile operating on a patient with chronic uveitis presents some challenges, there are a few pearls that may increase success.
Latest:
Enhanced OCT GA segmentation achieved with new multistage modelResearchers introduce a multistage dual-branch network to improve accuracy and efficiency.
Latest:
Promoting Treatment Adherence in nAMD and DMEExperts conclude the series with the hope that longer-acting agents will lead to better real-world outcomes for patients, mirroring clinical trial results and potentially preventing vision loss, especially in countries with limited access to healthcare.
Latest:
Is complement therapy the path forward for geographic atrophy?Clinical benefit of complement inhibition has been demonstrated in clinical trials, but there are possible consequences to consider.
Latest:
Optos ushers in new generation of imaging with MonacoPro ultra-widefield and OCTMonacoPro, the next evolution of Monaco from Optos, retains the powerful ultra-widefield SLO and spectral domain imaging while adding additional key product features.
Latest:
Adapting medical retina service in COVID-19 era requires careful approachMinimizing clinic visits, maximizing use of imaging modalities are key
Latest:
ABVC BioPharma announces approved plan for pilot Good Manufacturing Practice (GMP) facility to produce VitargusThe plan is intended to upgrade Vitagrus’ manufacturing process so that it can ultimately handle the global market supply.
Latest:
Successful treatment of bilateral diffuse Uveal melanocytic proliueration with plasmapheresisNonetheless,BDUMP remains a rare condition with fewer than 60 cases documented in literature.
Latest:
New guidelines boost choriocapillaris imaging in AMD with SS-OCTACompensation techniques in swept-source optical coherence tomography angiography improve accuracy by correcting signal loss from drusen and other artifacts.
Latest:
Expert Insights: Ramiro Ribeiro, MD, PhD, discusses next steps in EYP-1901 researchRamiro Ribeiro, MD, PhD, shares insights from the ongoing research tyrosine kinase inhibitors for AMD and DME.
Latest:
Ultra-widefield imaging: A critical step in uveitis diagnosis and managementA multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.
Latest:
Q&A: The increasing potential of ERG in diagnosing a wide range of eye conditionsEasier, more accessible functional studies have been made possible
Latest:
Humanity + technology: Talking to patients about the science and benefits of clinical trialsWhen we discuss trial participation with patients, we stress that the goal of these studies is to obtain better visual outcomes and ease the treatment burden.
Latest:
The unique role of the retina optometristZhang’s journey as the first retina optometrist in Colorado
Latest:
COVID-19 pandemic highlights the power of electronic health recordsElectronic health records may be the future of practice management.
Latest:
Novel Intravitreal Injections: Faricimab and Aflibercept 8mg for the Treatment of Retinal DiseasesPanelists discuss how novel intravitreal agents faricimab and high-dose aflibercept 8mg offer potential advantages in treating retinal diseases through their extended durability and dual mechanism of action.
Latest:
Bayer files EMA application for aflibercept 8mg in third indication, retinal vein occlusionIn the European Union and the United Kingdom, aflibercept 8mg (Eylea HD in the US) is currently approved for neovascular age-related macular degeneration and diabetic macular edema.
Latest:
Emerging insights into ocular immune-related diseases and treatment optionsIn this study, researchers examine immune mechanisms in ocular diseases like uveitis, AMD, DR, and GO, highlighting microglial roles, targeted therapies, and promising advances in immunotherapy.
Latest:
High-resolution multimodal imaging is key in dry AMD therapeutic development, future managementIn an attempt to halt the progression of dry AMD and geographic atrophy, the use of high-resolution optical coherence tomography becomes pivotal.
Latest:
Effectiveness Of Pegcetacoplan In Preserving Visual Function In Geographic AtrophyDr Charles Wykoff presents the results of a post hoc microperimetry analysis from the OAKS study demonstrating the effectiveness of pegcetacoplan in preserving visual function.
Latest:
Wet AMD therapeutics: Technologies raising the ceiling for functional visual outcomesNeovascular macular degeneration is multifactorial, which requires future agents to target multiple pathways.
Latest:
Where might AI be heading?A look at the current state of AI in diabetic eye disease and where the future may take us.
Latest:
AAO 2024: Bonnie An Henderson, MD, explores future of medical education in Kelman LectureHenderson’s presentation touches on the shift in medical education from traditional learning to AI and robotics.
Latest:
Clinical Implications of Port Delivery System in Retinal DiseasesClosing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.
Latest:
Vitrectomy: Is higher speed always better?Physicians should consider hydrodynamic cavitation when performing this procedure.
